MDD(Mild Cognitive Impairment Delirium Dementia) Cohort
A Prospective, Longitudinal Cohort Study of the Incidence of Dementia After the Onset of Delirium in Patients With Mild Cognitive Impairment: MDD Cohort (Mild Cognitive Impairment Delirium Dementia)
1 other identifier
observational
163
1 country
2
Brief Summary
- Identify the degree of delirium in subjects with mild cognitive impairment and find the risk factors of delirium. Mortality, hospital stay, and medical expenses are analyzed as clinical consequences related to delirium incidence.
- Dementia conversion rate and conversion period of subjects with mild cognitive impairment with delirium and it identifies the effect of delirium on dementia conversion.
- Develop an AI(Artificial intelligence) algorithm for predicting dementia transition in subjects with mild cognitive impairment based on the research results of the 1st, 2nd, and 3rd years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2021
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 17, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 1, 2022
July 1, 2022
1.3 years
October 17, 2021
July 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Delirium incidence in participants with mild cognitive impairment
descriptive statistics
The number of subjects evaluated as positive in the delirium assessment using S-CAM for 30 days from the 1st day of study participation is statistically calculated.
Dementia conversion rate and transition period in participants with mild cognitive impairment
descriptive statistics
The participant's dementia conversion is checked in units of 1 month, and the period until conversion to dementia is analyzed in units of 12 months for 36 months.
Secondary Outcomes (4)
Risk factors affecting participants' delirium
On the first day of data collection, the characteristics of subjects are collected through medical records. After 12 months, the risk factors affecting the occurrence of delirium among the characteristics of the subject are analyzed.
Mortality
It is statistically calculated in 30-day, 60-day, 12-month, 24-month, and 36-month increments.
hospital length of stay
The period from hospitalization to discharge is calculated in days and analyzed in units of 12 months.
healthcare costs
From the healthcare costs consumed during the hospital length of stay, the direct healthcare costs used only for treatment are calculated in won units and analyzed in units of 12 months.
Study Arms (1)
MCI(Mild Cognitive Impairment) group
* Inclusion criteria : Patients 65 years of age or older who are admitted to a LTC(long-term care) facilities, Patients diagnosed with mild cognitive impairment by doctors, Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination * Exclusion criteria : Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems, Patients with serious psychiatric or neurological diagnosis,Patients who died or were transferred on the day of admission, Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances
Interventions
Twice a day, the rounds of nurses in shifts, 8:00 am - 10:00 am, 4:00 pm - 6:00 pm Trained research assistants assessed delirium using S-CAM
Eligibility Criteria
Patients admitted to 3 long-term care (LTC) facilities
You may qualify if:
- Patients 65 years of age or older who are admitted to a LTC
- Patients diagnosed with mild cognitive impairment by doctors
- Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination
You may not qualify if:
- Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems
- Patients with serious psychiatric or neurological diagnosis,Patients who expire or were transferred on the day of admission -
- Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Yangsan Seoul long-term care (LTC) facilities
Daegu, Gyeongsangnam-do, 50572, South Korea
Gunsan Chamsarang long-term care (LTC) facilities
Daegu, Jeollabuk-do, 54078, South Korea
Related Publications (1)
Moon KJ, Park M. Protocol for a prospective, longitudinal cohort study on the incidence of dementia after the onset of delirium in patients with mild cognitive impairment: MDDCohort (Mild Cognitive Impairment Delirium Dementia). BMC Geriatr. 2024 Nov 7;24(1):922. doi: 10.1186/s12877-024-05480-6.
PMID: 39511473DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 17, 2021
First Posted
November 9, 2021
Study Start
July 1, 2021
Primary Completion
October 31, 2022
Study Completion
December 31, 2025
Last Updated
August 1, 2022
Record last verified: 2022-07